Company Filing History:
Years Active: 2017-2022
Title: Lambertus Benthem: Innovator in Metabolic Disease Treatment
Introduction
Lambertus Benthem is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of metabolic disease treatment, particularly in obesity management. With a total of 3 patents to his name, Benthem is recognized for his innovative approaches to healthcare.
Latest Patents
Among his latest patents, Benthem has developed glucagon/GLP-1 agonists for the treatment of obesity. This disclosure provides GLP-1/glucagon agonist peptides aimed at addressing metabolic diseases, such as obesity. His work in this area highlights the potential for new therapeutic options in managing weight-related health issues.
Career Highlights
Benthem is currently associated with MedImmune Limited, where he continues to advance research in metabolic diseases. His expertise and dedication to innovation have positioned him as a key figure in the development of new treatments.
Collaborations
Some of his notable coworkers include Balaji Agoram and Madeleine Antonsson, who contribute to the collaborative efforts in research and development at MedImmune Limited.
Conclusion
Lambertus Benthem's work in the field of metabolic disease treatment exemplifies the impact of innovation in healthcare. His patents and ongoing research efforts are paving the way for new solutions to combat obesity and improve patient outcomes.